AYTU BioPharma, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for AYTU, updated each market day.
AYTU AI Sentiment
AI sees no strong directional signal for AYTU BioPharma, Inc. Common Stock stock over the next 10 market days.
Prediction date: Oct. 9, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About AYTU BioPharma, Inc. Common Stock
Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.
Sector
Exchange
Market Cap
$22,276,751
Cap Tier
Employees
76
Headquarters
DENVER, CO
Listed Since
Feb. 15, 2008
Website
AYTU Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
AYTU Volatility
AYTU BioPharma, Inc. Common Stock has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
